Silodosin

Pediatric
CLINICALLY IMPORTANT, POTENTIALLY HAZARDOUS INTERACTIONS WITH:

Alpha blockers, Antihypertensives, Atorvastatin, Clarithromycin, Conivaptan, Cyclosporine, Darunavir, Delavirdine, Diltiazem, Erythromycin, Indinavir, Itraconazole, Ketoconazole, Lapatinib, Ritonavir, Stong CYP3A4 inhibitors, Telithromycin, Vasodilators, Verapamil, Voriconazole

PREGNANCY CATEGORY: B
Not indicated for use in women

Contra-indicated in patients with severe hepatic or renal impairment.

Our database has 24 adverse reactions for this drug across the following areas

Please login to see the rest of this drug profile


Not a subscriber? Click here to subscribe

SKIN
MUCOSAL
CARDIOVASCULAR
CENTRAL NERVOUS SYSTEM
GASTROINTESTINAL/HEPATIC
GENITOURINARY
HEMATOLOGIC
NEUROMUSCULAR/SKELETAL
RESPIRATORY
OTHER


Page last updated 09/19/2018

Drug Eruption Mobile Site

Symbol key

Incidence info

  • <1%
  • 1-5%
  • 5-10%
  • 10-15%
  • 15-20%
  • 20-30%
  • >30%

Seriousness info

  • Hospitalization possible
  • Life threatening
  • Fatal

Warnings in other populations info

  • Breast feeding
  • Geriatric
  • Pediatric
^ Back to top